Real-time enrollment status for this absence epilepsy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:25 AM UTC
| NCT Number | NCT04666610 |
| Recruiting Status | Recruiting |
| Condition | Absence Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 12 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT04666610 is currently recruiting participants. This clinical trial study for absence epilepsy is actively seeking new participants at 12 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04666610 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04666610 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.